Skip to main content
← All comparisons

Best Biopharma MCP Servers and Claude Connectors in 2026

Maven Bio provides live intelligence that combines connected biopharma evidence with monitoring and maintained research files1. For example, Maven Bio brings linked drug, trial, and company research into Claude2, AdisInsight supplies development and safety operations3, and BioMCP retrieves public biomedical records4.

This guide compares biopharma MCP servers and Claude connectors in 2026 by the records they return, the research operations they expose, and the assistant environments they document235. A biopharma intelligence MCP server can connect an assistant to linked drug, trial, and company evidence, while the provider's documented operations determine the research available through that connection25.

Best Biopharma MCP Servers and Claude Connectors in 2026

Jump to a connector

How we assessed these platforms

We examined the providers' own connector documentation, product pages, and maintained repositories. The comparison asks what an assistant can retrieve, how that answer is grounded, and which operations belong to the provider rather than the host. Maven Bio publishes this guide, and its own entry is held to the same evidence standard, with every claim linked to a public page.

CriterionWhat we checked
Connected evidenceDrug, clinical, company, and scientific records reachable through the service
Retrieval functionsSearch, record detail, change queries, and supported analysis operations
Answer provenanceLinks and source metadata accompanying returned information
Host supportNamed assistants and documented MCP-compatible environments
Research continuityMonitoring and maintenance available beyond an individual retrieval

The guide does not give an overall score. Teams weigh these criteria differently, so each entry below names the work the platform suits best, its published coverage, its price on record, and its limitations, and the quick picks above match platforms to common use cases10.

Biopharma assistant research tasks compared

Maven Bio combines linked biopharma research with monitored developments2. AdisInsight exposes drug, trial, change, and safety operations through its server3. Maven Bio states that it does not produce a proprietary consensus sales forecast dataset, whereas Cortellis CCI makes consensus sales forecasts available in its assistant research service115.

ProviderDrug or asset researchClinical-trial researchCompany or deal researchFile delivery and maintained revisionsProvider consensus sales forecast dataset
Maven Bio12YesYesYesPlatform edits, history, and rollbackNo11
AdisInsight3YesYesYesCharts, timelines, and source XMLNot described
BioMCP412YesYesNot describedStructured JSON and CLI outputNot described
Anthropic Clinical Trials713Studies by interventionYesStudies by sponsorRegistered-study detailsNot described
Cortellis Competitive Intelligence MCP514YesClinical evidence in drug recordsYesCSV search results and visualizationsYes5
Gosset815YesYesYesAgentic reports with artifactsNot described
Pharma Observatory916YesYesYesSource-linked records and APINot described

Not described means the provider's public pages do not document it.

Prices on record

Quote only means no price is published.

ProductPrice on record
Maven BioQuote only17
AdisInsightQuote only6
BioMCPNo software license fee under MIT18
Anthropic Clinical TrialsIncluded with a Claude plan; no separate connector charge listed7.
Cortellis Competitive Intelligence MCPQuote only5
GossetFree $0/month; Team and Enterprise quote only15
Pharma ObservatoryIndividual $199/seat/month; Team $299/seat/month16

Maven Bio

Best for

Biopharma research that combines connected records, supporting documents, and monitored developments with work maintained in the Maven Bio platform.

Maven Bio provides live intelligence that follows a team's priorities and applies source-linked edits to selected project files. Word, Excel, and PowerPoint outputs remain available for download. The platform's maintained-file workflow includes inspection of the evidence, revision history, and rollback1.

Biopharma data is built in and connected across drugs, companies, trials, indications, deals, and financings. The Claude listing describes research across those records and retrieval of supporting filings, papers, releases, and abstracts. It also names monitors for FDA actions, clinical trial readouts, and company announcements2.

The connector page documents retrieval of drugs, companies, trials, indications, mechanisms, and targets with linked records and aliases, together with scoped monitoring findings and saved artifacts available to the account19. It describes a remote MCP connection using OAuth, with directory routes for Claude and ChatGPT and a Microsoft Marketplace route for Microsoft 365 Copilot19. The page asks teams to confirm Gemini support for their particular product and edition19.

Beyond the connector, Maven Bio's integration page describes packaged research methods for asset assessments, comparisons, and event research in Claude20. API queries and webhook notifications provide a separate route for structured records and new monitoring findings to reach an internal application, without changing the MCP interface's read-only scope2019.

Coverage

The October 2026 Maven Bio FAQ reports 100,000+ drug products and 30,000+ companies across all therapeutic areas, supported by 11 source classes21.

Price on record

Quote only17. Maven Bio prices annual team access with pooled AI credits and a defined scope for the data license, assistant connections, API volume, and product integrations17.

Pros

Linked records and source material support scientific and commercial research in the same investigation2; MCP, API, and connectors carry intelligence into assistants and other systems20.

Cons

No proprietary consensus sales forecasts11.

AdisInsight

Best for

Researching drug-development histories, trial status, and safety information through an assistant.

AdisInsight's MCP service describes drug and trial search, detailed retrieval, development changes, and safety-report research. A development query can identify changes in a program's status, while trial operations retrieve the records relevant to a clinical question. Drug details can include pharmacology, milestones, deals, and patents3.

Timeline and chart operations organize drug and trial records. The server can also return the underlying AdisInsight document as XML3.

Drug searches accept combinations of disease, phase, company, mechanism, target, formulation, route, country, designation, and date, while trial filters include patients and results3. Related-resource operations retrieve paginated tables with totals, allowing an assistant to follow an initial profile into its development history, organizations, trial centers, or investigators3.

The knowledge-base function explains the fields and record relationships, search-value matching, and questions outside the data's scope3. Individual trial detail can include eligibility, intervention descriptions, results, and endpoints, while the drug timeline can preserve separate development lines by country, route, formulation, and patient group3.

Coverage

The MCP service describes a safety-report collection of about 347,000 records. This is a safety-report total, separate from drug and trial inventories3. The server lists 17 research operations, including separate functions for finding drug-development changes and trial-status changes over a specified period3.

Price on record

Quote only6. No subscription figure is displayed on the AdisInsight product page, which offers a route to discuss requirements with its team6.

Pros

Drug, trial, status-change, and safety operations support several stages of a development investigation3; timelines and charts provide structured views alongside retrieved research3.

Cons

The chart function supports grouping by only one or two fields, constraining more complex multidimensional views3.

BioMCP

Best for

Research workflows that query public biomedical sources through an MCP server or command-line interface.

BioMCP provides search and retrieval across biomedical information such as publications, genes, variants, drugs, diseases, and trials. Its documentation identifies the upstream sources used for different record types. The project offers both command-line and MCP interfaces, which support scripted research as well as assistant conversations4.

The maintained repository describes trial retrieval through ClinicalTrials.gov and the National Cancer Institute's Clinical Trials Search service. It also describes entity links, batch operations, and metadata identifying section sources12.

Its documented MCP configuration runs a local executable, and a separate HTTP server command supports shared or remote deployments12. The repository includes distribution instructions for Docker, Claude Code, Codex, and manual MCP client configurations, so the connection model differs from a directory-only hosted service12. Record retrieval supports selected sections, and JSON output provides suggested next commands along with section-level source metadata12.

Cross-entity commands connect drugs, diseases, genes, trials, articles, and other record types, while a combined search can begin with counts across entity categories12. The project also documents gene-set enrichment and local study analysis, with optional source credentials affecting some upstream functions and request limits12.

Coverage

BioMCP documents direct retrieval from 72 biomedical sources, with a further 10 sources appearing inside other providers' responses12.

Price on record

The MIT license permits use, modification, and distribution of BioMCP without a software license charge, subject to retaining its copyright and permission notice18.

Pros

Public biomedical sources can be queried through both assistant and programmatic interfaces4; source metadata and entity links help preserve the origin and context of retrieved material12.

Cons

Explicit source selection in article search disables cross-provider row enrichment, reducing the combined context returned in that mode12.

Anthropic Clinical Trials

Best for

Looking up ClinicalTrials.gov studies and their registered details directly in Claude.

Anthropic's Clinical Trials connector searches ClinicalTrials.gov and retrieves study details. Its listing identifies eligibility, sponsors, investigators, and other trial information as research targets. This gives Claude a direct route to a defined trial registry7.

Anthropic's tutorial says trial searches can filter by condition, intervention, location, sponsor, recruitment status, and phase, while detailed retrieval includes study design, endpoint timeframes, enrollment, locations, and links to published results13. Endpoint analysis can examine a single study or patterns across multiple studies, which is a distinct research operation from finding a trial identifier13.

Sponsor searches support a company-centered view of registered studies, while investigator searches return roles, affiliations, facilities, and associated studies13. Eligibility searches use demographic criteria and keywords from the registered inclusion and exclusion text, retaining ClinicalTrials.gov as the underlying evidence source for these operations13.

Coverage

The connector listing specifies ClinicalTrials.gov as its source without a study count, while Anthropic's current tutorial describes access to more than 600,000 registered studies713. The directory lists 6 operations, covering general trial search, detailed study retrieval, eligibility search, endpoint analysis, investigator search, and sponsor search7.

Price on record

Included with a Claude plan; no separate connector charge listed7.

Pros

Claude can search and retrieve registered trial information through an Anthropic-built connector7; eligibility and study-detail research have a clearly identified source7.

Cons

Its ClinicalTrials.gov-only scope excludes a separate company, deal, patent, or regulatory-document collection7.

Cortellis Competitive Intelligence MCP

Best for

Assistant-based research into drug development, company pipelines, and commercial relationships in Cortellis.

Clarivate's CCI MCP documentation describes drug details, development status by indication and country, company pipelines, deals, and consensus forecasts. Responses can link to the underlying Cortellis record. The service therefore connects an assistant to commercial and development information as well as asset descriptions5.

The documentation distinguishes structured drug-overview information from AI-summarized details. It also describes analytical planning, search output, and visualizations in supported environments. Those functions can help organize a company or landscape assessment around the specific records being retrieved5.

The service's search operations include drug and deal discovery, while entity finding helps resolve indications, mechanisms, technologies, and companies before detailed retrieval5. A drug overview returns compact structured information and section-size metadata, whereas a drug-detail request produces an answer tailored to the user's question5. A separate section operation retrieves a selected portion of a drug record in bounded chunks, and drug search can return CSV data5.

Analytical execution uses a validated plan against a provider-backed dataset, with a separate validation operation and optional visualization in hosts supporting the MCP application interface5. The supported delivery routes include Claude, custom Microsoft Copilot Studio agents, and server-to-server access, each described separately in the documentation5.

Coverage

Clarivate reports over 80,000 drugs and biologics across more than 2,300 diseases for its drug-information collection, including inactive development records14.

Price on record

Quote only5. The CCI MCP documentation requires an active Cortellis subscription but does not publish a separate connector price5.

Pros

Company pipelines, deals, and forecasts can accompany drug-development research5; links to Cortellis records provide a route from an assistant response to the underlying entry5.

Cons

CCI MCP does not currently support Microsoft 365 Copilot Chat5.

Gosset

Best for

Building clinical and preclinical landscapes through an assistant, then following the supporting research.

Gosset's documentation describes research across assets, companies, trials, preclinical experiments, patents, and licensing deals. The main workflow begins with a target, disease, or modality question and continues through the evidence behind the landscape. Its public pages identify both Claude and ChatGPT connections8.

The Claude guide describes selecting Gosset from the connector directory and using it within a conversation. The broader documentation also supports custom MCP-compatible agents2223.

The custom-agent guide supports a remote MCP connection and documents both current HTTP and older event-stream connection routes23. Its Claude instructions separate adding the connector to an organization from authorizing the individual Gosset account, and explain how to verify that the assistant actually used the connection in its response22. The documented research sequence proceeds from an asset landscape into trial references and supporting preclinical experiments, retaining those evidence types as distinct parts of the investigation22.

Gosset's pricing page includes web, API, command-line, and MCP access on the free plan, with 1 agentic research report per rolling 30-day period15. Direct queries use their own data and query allowances, while a report includes analysis and supporting artifacts15.

Coverage

Gosset lists 190K+ companies, 150K+ drugs, 1M+ trials, 90K+ trials with results, and 180K+ deals24.

Price on record

Free is $0 per month, while Team uses contact-based pricing and Enterprise is custom quoted15.

Pros

Clinical and preclinical asset research can be followed into experiments, patents, and licensing evidence8; documented Claude, ChatGPT, and custom-agent routes support different research environments2223.

Cons

On datasets with a quota, each plan caps how many unique records an account can see in rolling 365-day and 30-day windows, and requests for that dataset are refused once the cap is reached25.

Pharma Observatory

Best for

Exploring relationships among public trial, company, patent, and regulatory records.

Pharma Observatory describes connected records for trials, drugs, companies, investigators, sites, patents, funding, and FDA enforcement. Its site presents research that follows those relationships and returns to source records. The clinical-trial collection is based on ClinicalTrials.gov9.

Pharma Observatory documents MCP connections for Claude Desktop, ChatGPT, Claude Code, and Codex. The assistant can search connected records and return to the underlying registry entry, filing, or publication behind a figure9.

A public MCP endpoint returns the trimmed data shown on condition, biomarker, and organization pages without an account, while paid plans include the fuller research operations and records9. The product matches alternate drug names, company subsidiaries, and investigator identifiers across public sources, keeping uncertain matches separate when the evidence is insufficient9. Its condition hierarchy follows MeSH, so a therapeutic-area search can include the narrower indications beneath it9.

The public source list includes trial registries, FDA records, corporate filings, publications, and research funding, with individual figures linked to their underlying records9. Pharma Observatory also states that its people and hospital coverage is fuller in the United States because of the geography of its payment and hospital sources9.

Coverage

Pharma Observatory reports 610,000+ trials, 360,000+ organizations, 800,000+ publications, and 4,600+ molecules. Its page says counts are rounded down to two significant figures9.

Price on record

Individual is $199 per seat per month or $1,990 per seat per year, and Team is $299 per seat per month or $2,990 per seat per year, in US dollars excluding tax16.

Pros

Public records connect trial research with company, patent, and regulatory context9; source links support inspection of the records behind a relationship9.

Cons

Clinical-trial coverage is based on ClinicalTrials.gov, limiting the registry scope of that part of the product9.

How to choose a biopharma MCP server or Claude connector

Begin with the research decision and the records needed to support it, distinguishing a literature investigation, a company pipeline assessment, and a transaction question through the operations each provider documents1235. Trial details can include eligibility and endpoints, while development research can require status histories, country-specific records, or linked commercial information, so specify the actual fields the assistant must retrieve1335. Also identify whether the intended investigation needs paginated records, batch retrieval, source documents, or a summarized response, because those are separately documented operations within the services3125.

Next, check where the work ends up after retrieval and how new evidence reaches the recurring assessment used by the team120. Maven Bio describes maintained platform files alongside a read-only MCP connection, while other providers expose charts, downloadable records, or analytical responses for use in the chosen assistant11935. Inspect the host's supported interaction as part of that evaluation, since Cortellis distinguishes rich visualizations from ordinary record retrieval and expressly identifies which Microsoft assistant environments it supports5.

Use your own programs to test the provider and the chosen assistant together, checking the requested fields and following source links into the supporting record239. Verify whether an answer used a combined source search, a restricted public endpoint, or the complete account-accessible collection, because BioMCP, Pharma Observatory, and Maven Bio document different boundaries for those retrieval routes12919. Retain the deployment and commercial terms in the evaluation, including the local server option in BioMCP, the data and query allowances in Gosset, and the named-user and integration terms of commercial services12151617.

Frequently asked questions

What is a biopharma intelligence MCP server?

It exposes a provider's research operations to a compatible assistant, such as drug search, trial-detail retrieval, and access to supporting documents23. Maven Bio and AdisInsight show how the same connection standard can provide different record collections and research functions23.

Is a Claude connector the same as a biopharma database?

A connector is an access route to a service whose underlying evidence remains provider-specific27. Maven Bio connects linked biopharma records and supporting documents, while Anthropic Clinical Trials focuses on the ClinicalTrials.gov registry27.

Which connections support clinical trial readouts?

Maven Bio explicitly lists trial-readout monitoring, while AdisInsight offers development-change and trial research and BioMCP retrieves studies from identified public sources234. Monitoring a newly released result and retrieving an existing study record are distinct operations within those documented offerings2312.

Can MCP connections maintain working files?

Maven Bio maintains selected files within its platform, while its MCP interface remains read-only119. An assistant requires separate document capabilities and permissions to use the retrieved evidence in an external file19.

Does every connector work in every assistant?

No, supported environments depend on the provider's documentation, and Cortellis CCI expressly excludes Microsoft 365 Copilot Chat while supporting other named clients5. MCP support alone does not mean a connector works in every assistant5.

How does a connector support pipeline monitoring?

A connection can retrieve current pipeline information, while monitoring requires repeated checks for relevant developments201. Maven Bio documents monitored findings and API webhooks alongside MCP access, so the availability of a database search alone does not establish scheduled checks or event notifications20.